

CLASSIFICATION: ANDROGEN; ANABOLIC STEROID
ACTIVE SUBSTANCE: OXYMETHOLONE
FORM: 20 TABLETS x 50 MG
ACTIVE HALF-LIFE: ~9 HOURS
DOSAGE: MEN 50-100 MG/DAY
ACNE: POSSIBLE / MODERATE–HIGH RISK
WATER RETENTION: HIGH
HIGH BLOOD PRESSURE (HBP): POSSIBLE / MONITOR LIPIDS & BP
HEPATOTOXICITY: HIGH (17Α-ALKYLATED ORAL)
AROMATIZATION: NONE
MANUFACTURER: ABDI IBRAHIM
Anapolon provides oxymetholone, a potent orally active anabolic-androgenic steroid (AAS) originally approved for specific anemias. While celebrated in physique circles for rapid mass and strength, oxymetholone is a Schedule III controlled medication in the U.S. and carries significant hepatic and cardiometabolic risks. It should be used only under licensed medical supervision and never as a shortcut for weight gain or fat loss.
Oxymetholone is a synthetic androgen that binds the androgen receptor (AR), stimulating protein synthesis and erythropoiesis. Clinically, it can raise red blood cell counts in selected anemias; in performance contexts, users often associate it with dramatic scale changes, pronounced pumps, and fast strength increases. Those effects, however, come with a cost profile that demands caution: liver strain, blood pressure rise, adverse lipid shifts (HDL↓, LDL↑), edema, and androgenic effects (e.g., acne, hair growth).
Oxymetholone is rapidly effective as an oral 17α-alkylated AAS. The exact elimination half-life has not been firmly established in modern human PK literature; many secondary sources report a roughly workday-length "active window," which is consistent with users noticing pronounced daily effects. Because formal half-life data are limited, dosing decisions should be conservative and clinically guided.
For refractory anemias, labeling describes ranges such as 1–5 mg/kg/day with response-based duration limits. That framework is not a license for non-medical use; rather, it underscores that oxymetholone is a serious drug reserved for physician-managed scenarios. If your clinician prescribes it, they will set your dose, monitoring plan, and stop criteria.
In mass-focused protocols, athletes often insist on a testosterone base for hormonal balance. Where clinical oversight exists, some pair a long ester test during the oral phase for foundation and transition. If estrogen-like symptoms arise (despite oxymetholone not aromatizing), clinicians may consider adjuncts mindful of patient-specific risks.
Hepatic: Androgenic steroids (especially 17α-alkylated orals) have been linked to cholestatic jaundice, peliosis hepatis, and benign/malignant liver tumors. Discontinue and seek medical care for severe RUQ pain, jaundice, dark urine, pale stools, or unexplained fatigue. Periodic LFTs are advisable in supervised therapy.
CV & Fluids: Edema and BP increases may occur, particularly with high sodium intake or concomitant steroids. Lipid profiles can deteriorate substantially, increasing atherosclerosis risk—another reason for limited duration and medical oversight.
Endocrine: Suppression of endogenous testosterone is common with AAS. Post-course recovery, when indicated by a clinician, often involves SERM-based protocols. Gynecomastia can occur even though oxymetholone does not aromatize, due to estrogen-like signaling pathways—monitor symptoms and labs rather than assuming "no aromatization = no gyno."
Because risk grows with duration and cumulative dose, conservative, physician-guided timelines are prudent. Many users report strong effects in short windows; however, "strong" does not equal "safe." Respect your clinician's stop dates, lab cadence, and contraindication checks.
For indications, contraindications, black-box hepatic warnings, interactions (e.g., warfarin potentiation), and dosage principles, consult the official labeling: FDA Prescribing Information for Oxymetholone (Anadrol-50).
This listing is for Abdi İbrahim Anapolon 50 mg (20 tablets). Store at controlled room temperature away from moisture and light. We ship discreetly across the USA with tracking. Keep out of reach of children.
Medical & legal disclaimer: Content provided for information only. Use prescription AAS only under licensed medical supervision and in accordance with local laws. Not medical advice.
No. Oxymetholone does not aromatize, but estrogen-like side effects (water retention, gynecomastia) can still occur via other mechanisms. Management should be lab-guided.
As a 17α-alkylated oral steroid, oxymetholone carries a high risk of cholestasis and other hepatic events. Discontinue and seek care for jaundice, severe abdominal pain, dark urine, or pale stools. Physician oversight and limited duration are essential.
For certain anemias, labels describe roughly 1–5 mg/kg/day with careful monitoring and finite duration. That framework is not permission for non-medical use; dosing must be physician-directed.
In many protocols, clinicians consider a testosterone base to maintain physiologic androgen levels. Choices, doses, and timing are individualized and should be guided by labs and medical supervision.
PCT is case-dependent. Where indicated, clinicians often choose SERMs (e.g., tamoxifen) and set timing based on the full stack and lab results. Do not self-prescribe; follow your provider's plan.
Please log in to write Anapolon review.
CLASSIFICATION: ANDROGEN; ANABOLIC STEROID
ACTIVE SUBSTANCE: OXYMETHOLONE
FORM: 100 PILLS x 50 MG
ACTIVE HALF-LIFE: 8 HOURS
DOSAGE: MEN 50-100 MG/DAY
ACNE: YES
WATER RETENTION: HIGH
HIGH BLOOD PRESSURE (HBP): YES
HEPATOTOXICITY: YES
AROMATIZATION: NO
MANUFACTURER: DRAGON PHARMA
LABORATORY TESTED: VIEW LAB RESULTS
CLASSIFICATION: ANDROGEN; ANABOLIC STEROID
ACTIVE SUBSTANCE: OXYMETHOLONE
FORM: 50 PILLS x 50 MG
ACTIVE HALF-LIFE: 8 HOURS
DOSAGE: MEN 50-100 MG/DAY
ACNE: YES
WATER RETENTION: HIGH
HIGH BLOOD PRESSURE (HBP): YES
HEPATOTOXICITY: YES
AROMATIZATION: NO
MANUFACTURER: KALPA PHARMACEUTICALS
CLASSIFICATION: ANDROGEN; ANABOLIC STEROID
ACTIVE SUBSTANCE: OXYMETHOLONE
FORM: 50 TABLETS x 50 MG
ACTIVE HALF-LIFE: 8–9 HOURS
DOSAGE: MEN 25–100 MG/DAY
ACNE: YES
WATER RETENTION: HIGH
HIGH BLOOD PRESSURE (HBP): POSSIBLE
HEPATOTOXICITY: HIGH
AROMATIZATION: INDIRECTLY (PROGESTIN-LIKE)
MANUFACTURER: AXIOLABS
CLASSIFICATION: ANABOLIC ANDROGENIC STEROID
ACTIVE SUBSTANCE: OXYMETHOLONE
FORM: 50 TABLETS × 50 MG
ACTIVE HALF-LIFE: 8–10 HOURS
DOSAGE: MEN 25–100 MG/DAY
ACNE: YES
WATER RETENTION: YES
HIGH BLOOD PRESSURE (HBP): COMMON
HEPATOTOXICITY: HIGH
AROMATIZATION: INDIRECT (PROGESTIN-LIKE EFFECT)
MANUFACTURER: BRITISH DRAGON PHARMACEUTICALS
CLASSIFICATION: ANDROGEN; ANABOLIC STEROID
ACTIVE SUBSTANCE: OXYMETHOLONE
FORM: 10 ML VIAL x 50 MG
ACTIVE HALF-LIFE: 8 HOURS
DOSAGE: MEN 50-100 MG/DAY
ACNE: YES
WATER RETENTION: YES
HIGH BLOOD PRESSURE (HBP): YES
HEPATOTOXICITY: YES
AROMATIZATION: NO
MANUFACTURER: DRAGON PHARMA, EUROPE
LABORATORY TESTED: VIEW LAB RESULTS
CLASSIFICATION: ORAL ANABOLIC STEROID (AAS)
ACTIVE SUBSTANCE: OXYMETHOLONE
FORM: 100 TABLETS (50 MG/TABLET)
ACTIVE HALF-LIFE: ~ 8-9 HOURS
DOSAGE: 25-100 MG DAILY
ACNE: HIGH
WATER RETENTION: HIGH
HIGH BLOOD PRESSURE (HBP): HIGH RISK
HEPATOTOXICITY: HIGH
AROMATIZATION: INDIRECT VIA ESTROGENIC PATHWAYS
MANUFACTURER: STEALTH LABS USA
LABORATORY TESTED: VIEW LAB RESULTS
SHIPPED WITHOUT LABEL!